Recent Developments in Nanoparticle Formulations for Resveratrol Encapsulation as an Anticancer Agent

Area of Science:

• Biomedical Engineering
• Nanotechnology
• Pharmacology

Background:

• Resveratrol, a polyphenol, exhibits anti-inflammatory and anticancer properties.
• Its therapeutic use is limited by poor water solubility, low bioavailability, and rapid metabolism.
• Nanoparticle delivery systems offer a solution to these limitations.

Purpose of the Study:

• To review advancements in nanoparticle-based resveratrol delivery systems.
• To highlight strategies for overcoming resveratrol's bioavailability and efficacy challenges.
• To explore the potential of enhanced resveratrol formulations in cancer therapy.

Main Methods:

• Review of existing literature on nanoparticle-based resveratrol delivery.
• Analysis of various nanoparticle types used for resveratrol encapsulation or conjugation.
• Evaluation of studies demonstrating improved resveratrol solubility, bioavailability, and anticancer activity.

Main Results:

• Numerous nanoparticle platforms (e.g., liposomes, gold nanoparticles, mesoporous nanoparticles) have been developed for resveratrol delivery.
• Resveratrol-loaded or conjugated nanoparticles significantly enhance water solubility and bioavailability.
• Nanoparticle formulations demonstrate superior anticancer potency compared to free resveratrol in preclinical studies.

Conclusions:

• Nanoparticle-based delivery systems are effective in overcoming the limitations of free resveratrol.
• These advanced delivery systems hold significant potential for improving resveratrol's anticancer therapeutic effectiveness.
• Further research into optimized nanoparticle formulations can unlock the full potential of resveratrol in cancer treatment.